06:42 AM EST, 11/13/2024 (MT Newswires) -- Gyre Therapeutics ( GYRE ) reported Q3 earnings Wednesday of $0.01 per diluted share, down from $0.05 a year earlier.
Revenue for the quarter ended Sept. 30 was $25.5 million, down from $32 million a year earlier.
Analysts' estimates were not readily available for comparison.